Guardant Health: Q4 Earnings Snapshot

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $139.9 million in its fourth quarter.

The Palo Alto, California-based company said it had a loss of $1.36 per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.40 per share.

The provider of oncology testing services posted revenue of $126.9 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $125.4 million.

For the year, the company reported that its loss widened to $654.6 million, or $6.41 per share. Revenue was reported as $449.5 million.

Guardant Health expects full-year revenue in the range of $525 million to $540 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Source